Abstract:Background: Progranulin gene (GRN) mutations are major causes of frontotemporal lobar degeneration. To date, 68 pathogenic GRN mutations have been identified. However, very few of these mutations have been reported in Asians. Moreover, some GRN mutations manifest with familial phenotypic heterogeneity. Here, we present a novel GRN mutation resulting in frontotemporal lobar degeneration with a distinct clinical phenotype, and we review reports of GRN mutations associated with familial phenotypic heterogeneity. Case presentation: We describe the case of a 74-year-old woman with left frontotemporal lobe atrophy who presented with progressive anarthria and non-fluent aphasia. Her brother had been diagnosed with corticobasal syndrome (CBS) with right-hand limb-kinetic apraxia, aphasia, and a similar pattern of brain atrophy. Laboratory blood examinations did not reveal abnormalities that could have caused cognitive dysfunction. In the cerebrospinal fluid, cell counts and protein concentrations were within normal ranges, and concentrations of tau protein and phosphorylated tau protein were also normal. Since similar familial cases due to mutation of GRN and microtubule-associated protein tau gene (MAPT) were reported, we performed genetic analysis. No pathological mutations of MAPT were identified, but we identified a novel GRN frameshift mutation (c.1118_1119delCCinsG: p.Pro373ArgX37) that resulted in progranulin haploinsufficiency. Conclusion: This is the first report of a GRN mutation associated with familial phenotypic heterogeneity in Japan. Literature review of GRN mutations associated with familial phenotypic heterogeneity revealed no tendency of mutation sites. The role of progranulin has been reported in this and other neurodegenerative diseases, and the analysis of GRN mutations may lead to the discovery of a new therapeutic target.

Progranulin mutations as risk factors for Alzheimer disease

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

Losing protein in the brain: the case of progranulin

Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis

Progranulin as a therapeutic target in neurodegenerative diseases

Structure, Function, and Mechanism of Progranulin; the Brain and Beyond

Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation

Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease.

Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review

Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes